These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3567364)

  • 21. Comparison of vasoactive intestinal peptide and isoproterenol relaxant effects in isolated cat airways.
    Altiere RJ; Diamond L
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):986-92. PubMed ID: 6725078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide relaxes isolated strips of human bronchus, pulmonary artery, and lung parenchyma.
    Saga T; Said SI
    Trans Assoc Am Physicians; 1984; 97():304-10. PubMed ID: 6535346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide histidine isoleucine and vasoactive intestinal polypeptide cause relaxation of opossum internal anal sphincter via two distinct receptors.
    Nurko S; Dunn BM; Rattan S
    Gastroenterology; 1989 Feb; 96(2 Pt 1):403-13. PubMed ID: 2535995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelium-dependent relaxation in isolated human arteries and veins.
    Thom S; Hughes A; Martin G; Sever PS
    Clin Sci (Lond); 1987 Nov; 73(5):547-52. PubMed ID: 3119275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of vasoactive intestinal polypeptide (VIP) on the neuromuscular complex in the bovine ovarian follicle wall.
    Liedberg F; Kannisto P; Owman C; Schmidt G
    J Auton Pharmacol; 1993 Jun; 13(3):201-9. PubMed ID: 8514821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP and vasoactive intestinal polypeptide relaxant responses in hamster isolated proximal urethra.
    Pinna C; Puglisi L; Burnstock G
    Br J Pharmacol; 1998 Jul; 124(6):1069-74. PubMed ID: 9720775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the relaxant effects of vasoactive intestinal peptide (VIP) and PHI on isolated brain arteries.
    Suzuki Y; McMaster D; Lederis K; Rorstad OP
    Brain Res; 1984 Nov; 322(1):9-16. PubMed ID: 6549149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral vascular effects of peptide histidine methionine in canine and bovine species.
    Suzuki Y; Satoh S; Lederis K; Rorstad O
    Pharmacology; 1991; 42(5):241-5. PubMed ID: 1876608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations.
    Morris JL; Murphy R
    Eur J Pharmacol; 1989 Mar; 162(2):375-9. PubMed ID: 2542061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of endothelial NO in the dilator effect of VIP on rat isolated pulmonary artery.
    Anaid Shahbazian ; Petkov V; Baykuscheva-Gentscheva T; Hoeger H; Painsipp E; Holzer P; Mosgoeller W
    Regul Pept; 2007 Mar; 139(1-3):102-8. PubMed ID: 17174416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of peptide histidine isoleucine in relaxation of cat lower esophageal sphincter.
    Biancani P; Beinfeld MC; Hillemeier C; Behar J
    Gastroenterology; 1989 Nov; 97(5):1083-9. PubMed ID: 2571542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: lack of influence by peptidase inhibitors.
    Altiere RJ; Diamond L
    Br J Pharmacol; 1984 Jun; 82(2):321-8. PubMed ID: 6145470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal polypeptide-sensitive cyclic adenosine monophosphate generating system in the rat portal vein.
    Amenta D; Iacopino L; Amenta F
    Arch Int Pharmacodyn Ther; 1988; 291():88-95. PubMed ID: 2835024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide.
    Absood A; Chen D; Wang ZY; Håkanson R
    Regul Pept; 1992 Aug; 40(3):323-9. PubMed ID: 1332142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI) in stimulating the secretion of prolactin from rat anterior pituitary cells in vitro.
    Inoue T; Kato Y; Koshiyama H; Yanaihara N; Imura H
    Neurosci Lett; 1988 Mar; 85(3):363-9. PubMed ID: 3362424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prejunctional inhibition of vasoactive intestinal peptide release.
    Grider JR; Makhlouf GM
    Am J Physiol; 1987 Jul; 253(1 Pt 1):G7-12. PubMed ID: 3605338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.
    Liu SF; Crawley DE; Evans TW; Barnes PJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):541-8. PubMed ID: 1738104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery.
    Jovanović A; Jovanović S; Tulić I; Grbović L
    Mol Hum Reprod; 1998 Jan; 4(1):71-6. PubMed ID: 9510014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasoactive intestinal peptide as a possible transmitter of nonadrenergic, noncholinergic relaxation of pulmonary artery.
    Kubota E; Sata T; Soas AH; Paul S; Said SI
    Trans Assoc Am Physicians; 1985; 98():233-42. PubMed ID: 3842197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodinated derivatives of vasoactive intestinal peptide (VIP), PHI and PHM: purification, chemical characterization and biological activity.
    McMaster D; Suzuki Y; Rorstad O; Lederis K
    Peptides; 1987; 8(4):663-76. PubMed ID: 3628082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.